Clinical Trials · NCT05479591
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
- Phase
- N/A
- Recruitment status
- Withdrawn
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 0
- Start date
- Jul 2022
- Locations
- See registry
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)